James Brady Joins Verona Pharma as Non-Executive Director
LONDON and RALEIGH, N.C., March 14, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
News
Sandoz targets growth opportunities in respiratory and complex generics through acquisition of respiratory device company Coalesce
Sandoz gains significant capabilities and assets in medical and drug device development that target major…
Sanofi provides update on Phase 2 study evaluating amcenestrant in ER+/HER2- advanced or metastatic breast cancer
Sanofi provides update on Phase 2 study evaluating amcenestrant in ER+/HER2- advanced or metastatic breast…
The Climate Pledge Announces Nearly 100 New Signatories, Including Maersk, SAP, Weyerhaeuser, Sunrun, and HARMAN, Bringing the Total to More Than 300 Companies Committed Worldwide
More than 300 businesses across 51 industries and 29 countries have now joined The Climate…
Novartis data again demonstrate age-appropriate development when Zolgensma is used presymptomatically, and post-hoc data reveal SMA Type 1 patients could speak, swallow and maintain airway protection
Children with three copies of SMN2 treated presymptomatically achieved age-appropriate milestones, including standing and walking;…
DNP, Uniadex and GMS Establish Philippine-based Logistics and Delivery Matching Service Joint Venture
TOKYO–(BUSINESS WIRE)–Dai Nippon Printing Co., Ltd. (DNP), Uniadex Ltd. (Uniadex) and Global Mobility Service Inc….
Ascendis Pharma A/S Announces Phase 3 PaTHway Trial of TransCon™ PTH in Adults with Hypoparathyroidism Met Primary and All Key Secondary Endpoints
– For the primary composite endpoint, TransCon PTH demonstrated a response rate of 78.7% compared…
Bitcoin 2022 Expecting Record Attendance
Miami, Florida–(Newsfile Corp. – March 13, 2022) – Miami will once again play host to…
OPPA Token to Hold a Conference Meet with Three Well Renowned Entrepreneurs 2nd April 2022
Leeds, United Kingdom–(Newsfile Corp. – March 13, 2022) – Post pandemic, OPPA token aims to…
NSFW.app Comes Out of the Beta Phase, Unveils New Features
London, United Kingdom–(Newsfile Corp. – March 13, 2022) – NSFW.app is excited to announce that…
LBank Exchange Will List Pando Token (PTX) on March 14, 2022
Internet City, Dubai–(Newsfile Corp. – March 12, 2022) – LBank Exchange, a global digital asset…
Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer
BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic…
FIRSTCASH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Remind Investors that a Class Action Lawsuit Has Been Filed Against FirstCash Holdings, Inc. and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#Action–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds…
NOTICE: C3.ai, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – AI
SAN DIEGO–(BUSINESS WIRE)–#AIstock–The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers…
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021 Conference…
Roivant to Present at Targeted Protein Degradation Conference
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, March 11, 2022 (GLOBE NEWSWIRE) —…
Inventiva announces filing of its 2021 Universal Registration Document and 2021 Annual Report on Form 20-F
Daix (France), Long Island City (New York, United States), March 11, 2022 – Inventiva (Euronext…
Cellectis to Participate in Two Upcoming Investor Conferences in March
NEW YORK, March 11, 2022 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS –…
AnPac Bio-Medical Sciences Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
PHILADELPHIA, March 11, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the…
Biogen to Present New Research at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD 2022)
CAMBRIDGE, Mass., March 11, 2022 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced the company will…